Literature DB >> 34903620

Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.

Bappaditya Chandra1, Nicole L Michmerhuizen2, Hazheen K Shirnekhi1, Swarnendu Tripathi1, Brittany J Pioso1, David W Baggett1, Diana M Mitrea1, Ilaria Iacobucci2, Michael R White1, Jingjing Chen3,4, Cheon-Gil Park1, Huiyun Wu5, Stanley Pounds5, Anna Medyukhina6, Khaled Khairy6, Qingsong Gao2, Chunxu Qu2, Sherif Abdelhamed2, Scott D Gorman1, Simranjot Bawa1, Carolyn Maslanka1,7, Swati Kinger1,7, Priyanka Dogra1, Mylene C Ferrolino1, Danika Di Giacomo8, Cristina Mecucci8, Jeffery M Klco2, Charles G Mullighan2, Richard W Kriwacki1,9.   

Abstract

NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9), retains a DNA-binding homeodomain, whereas others harbor other types of DNA- or chromatin-binding domains. NUP98 FOs have long been known to form puncta, but long-standing questions are how nuclear puncta form and how they drive leukemogenesis. Here we studied NHA9 condensates and show that homotypic interactions and different types of heterotypic interactions are required to form nuclear puncta, which are associated with aberrant transcriptional activity and transformation of hematopoietic stem and progenitor cells. We also show that three additional leukemia-associated NUP98 FOs (NUP98-PRRX1, NUP98-KDM5A, and NUP98-LNP1) form nuclear puncta and transform hematopoietic cells. These findings indicate that LLPS is critical for leukemogenesis by NUP98 FOs. SIGNIFICANCE: We show that homotypic and heterotypic mechanisms of LLPS control NUP98-HOXA9 puncta formation, modulating transcriptional activity and transforming hematopoietic cells. Importantly, these mechanisms are generalizable to other NUP98 FOs that share similar domain structures. These findings address long-standing questions on how nuclear puncta form and their link to leukemogenesis. This article is highlighted in the In This Issue feature, p. 873. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34903620      PMCID: PMC8983581          DOI: 10.1158/2159-8290.CD-21-0674

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  55 in total

1.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

Review 2.  Biomolecular Condensates in the Nucleus.

Authors:  Benjamin R Sabari; Alessandra Dall'Agnese; Richard A Young
Journal:  Trends Biochem Sci       Date:  2020-07-17       Impact factor: 13.807

3.  NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.

Authors:  Haiming Xu; Daria G Valerio; Meghan E Eisold; Amit Sinha; Richard P Koche; Wenhuo Hu; Chun-Wei Chen; S Haihua Chu; Gerard L Brien; Christopher Y Park; James J Hsieh; Patricia Ernst; Scott A Armstrong
Journal:  Cancer Cell       Date:  2016-11-23       Impact factor: 31.743

4.  Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains.

Authors:  Ann Boija; Isaac A Klein; Benjamin R Sabari; Alessandra Dall'Agnese; Eliot L Coffey; Alicia V Zamudio; Charles H Li; Krishna Shrinivas; John C Manteiga; Nancy M Hannett; Brian J Abraham; Lena K Afeyan; Yang E Guo; Jenna K Rimel; Charli B Fant; Jurian Schuijers; Tong Ihn Lee; Dylan J Taatjes; Richard A Young
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

5.  Composition-dependent thermodynamics of intracellular phase separation.

Authors:  Joshua A Riback; Lian Zhu; Mylene C Ferrolino; Michele Tolbert; Diana M Mitrea; David W Sanders; Ming-Tzo Wei; Richard W Kriwacki; Clifford P Brangwynne
Journal:  Nature       Date:  2020-05-06       Impact factor: 49.962

6.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Authors:  Hamid Bolouri; Jason E Farrar; Timothy Triche; Rhonda E Ries; Emilia L Lim; Todd A Alonzo; Yussanne Ma; Richard Moore; Andrew J Mungall; Marco A Marra; Jinghui Zhang; Xiaotu Ma; Yu Liu; Yanling Liu; Jaime M Guidry Auvil; Tanja M Davidsen; Patee Gesuwan; Leandro C Hermida; Bodour Salhia; Stephen Capone; Giridharan Ramsingh; Christian Michel Zwaan; Sanne Noort; Stephen R Piccolo; E Anders Kolb; Alan S Gamis; Malcolm A Smith; Daniela S Gerhard; Soheil Meshinchi
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

7.  NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.

Authors:  S P Romana; I Radford-Weiss; R Ben Abdelali; C Schluth; A Petit; N Dastugue; P Talmant; C Bilhou-Nabera; F Mugneret; M Lafage-Pochitaloff; M-J Mozziconacci; J Andrieu; J-L Lai; C Terre; K Rack; P Cornillet-Lefebvre; I Luquet; N Nadal; F Nguyen-Khac; C Perot; J Van den Akker; S Fert-Ferrer; C Cabrol; C Charrin; I Tigaud; H Poirel; M Vekemans; O A Bernard; R Berger
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528

8.  Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.

Authors:  Katherine R Calvo; David B Sykes; Martina P Pasillas; Mark P Kamps
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

9.  Nup98 recruits the Wdr82-Set1A/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells.

Authors:  Tobias M Franks; Asako McCloskey; Maxim Nikolaievich Shokirev; Chris Benner; Annie Rathore; Martin W Hetzer
Journal:  Genes Dev       Date:  2017-12-21       Impact factor: 11.361

10.  Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

Authors:  Xiaotu Ma; Yu Liu; Yanling Liu; Ludmil B Alexandrov; Michael N Edmonson; Charles Gawad; Xin Zhou; Yongjin Li; Michael C Rusch; John Easton; Robert Huether; Veronica Gonzalez-Pena; Mark R Wilkinson; Leandro C Hermida; Sean Davis; Edgar Sioson; Stanley Pounds; Xueyuan Cao; Rhonda E Ries; Zhaoming Wang; Xiang Chen; Li Dong; Sharon J Diskin; Malcolm A Smith; Jaime M Guidry Auvil; Paul S Meltzer; Ching C Lau; Elizabeth J Perlman; John M Maris; Soheil Meshinchi; Stephen P Hunger; Daniela S Gerhard; Jinghui Zhang
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

View more
  11 in total

1.  Genetic variation associated with condensate dysregulation in disease.

Authors:  Salman F Banani; Lena K Afeyan; Susana W Hawken; Jonathan E Henninger; Alessandra Dall'Agnese; Victoria E Clark; Jesse M Platt; Ozgur Oksuz; Nancy M Hannett; Ido Sagi; Tong Ihn Lee; Richard A Young
Journal:  Dev Cell       Date:  2022-07-08       Impact factor: 13.417

Review 2.  Biomolecular Condensation: A New Phase in Cancer Research.

Authors:  Anupam K Chakravarty; Daniel J McGrail; Thomas M Lozanoski; Brandon S Dunn; David J H Shih; Kara M Cirillo; Sueda H Cetinkaya; Wenjin Jim Zheng; Gordon B Mills; S Stephen Yi; Daniel F Jarosz; Nidhi Sahni
Journal:  Cancer Discov       Date:  2022-09-02       Impact factor: 38.272

3.  Molecular interactions of FG nucleoporin repeats at high resolution.

Authors:  Alain Ibáñez de Opakua; James A Geraets; Benedikt Frieg; Christian Dienemann; Adriana Savastano; Marija Rankovic; Maria-Sol Cima-Omori; Gunnar F Schröder; Markus Zweckstetter
Journal:  Nat Chem       Date:  2022-09-22       Impact factor: 24.274

Review 4.  A conceptual framework for understanding phase separation and addressing open questions and challenges.

Authors:  Tanja Mittag; Rohit V Pappu
Journal:  Mol Cell       Date:  2022-06-07       Impact factor: 19.328

Review 5.  Oncogenic fusion proteins and their role in three-dimensional chromatin structure, phase separation, and cancer.

Authors:  Ivana Y Quiroga; Jeong Hyun Ahn; Gang Greg Wang; Douglas Phanstiel
Journal:  Curr Opin Genet Dev       Date:  2022-04-12       Impact factor: 4.665

Review 6.  Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies.

Authors:  Richoo B Davis; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

7.  SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.

Authors:  Zivojin Jevtic; Vittoria Matafora; Francesca Casagrande; Fabio Santoro; Saverio Minucci; Massimilliano Garre'; Milad Rasouli; Olaf Heidenreich; Giovanna Musco; Jürg Schwaller; Angela Bachi
Journal:  J Exp Clin Cancer Res       Date:  2022-01-24

Review 8.  Modulating biomolecular condensates: a novel approach to drug discovery.

Authors:  Diana M Mitrea; Matthäus Mittasch; Beatriz Ferreira Gomes; Isaac A Klein; Mark A Murcko
Journal:  Nat Rev Drug Discov       Date:  2022-08-16       Impact factor: 112.288

Review 9.  Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?

Authors:  Yasuyo Ohguchi; Hiroto Ohguchi
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 10.  Phase separation in immune regulation and immune-related diseases.

Authors:  Ning Huang; Hao Dong; Bin Shao
Journal:  J Mol Med (Berl)       Date:  2022-09-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.